Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate
Authors:
- Cristina LutmanCLCristina Lutman
- Gherardo FinocchiaroGFGherardo Finocchiaro
- Elena AbateEAElena Abate
- Marco MiloMMMarco Milo
- Pia MorassiPMPia Morassi
- Gianfranco SinagraGSGianfranco Sinagra
- 1 December 2014
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 15 (12) , 880-882
Abstract
Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexateKeywords
This publication has 11 references indexed in Scilit:
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- Advances in rheumatology: new targeted therapeuticsArthritis Research & Therapy, 2011
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trialsAnnals of the Rheumatic Diseases, 2009
- Indicators of Poor Prognosis of Acute PericarditisCirculation, 2007
- PericarditisThe Lancet, 2004
- Purulent pericarditis: Rediscovery of an old remedyThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Anaerobic Pericarditis: Case Report and ReviewClinical Infectious Diseases, 1994
- Purulent pericarditis: Review of a 20-year experience in a general hospitalJACC, 1993
- The changed spectrum of purulent pericarditisThe American Journal of Medicine, 1977
- Clinical, microbiologic and therapeutic aspects of purulent pericarditisThe American Journal of Medicine, 1975